Senores Pharmaceuticals IPO Debut
Senores Pharmaceuticals made an impressive debut today, December 30, 2024!
📈 Shares listed at ₹593.70 on the BSE, a 51.84% premium over the IPO price of ₹391.
📊 On the NSE, they opened at ₹600, reflecting a 53.45% premium.
💥 The IPO was oversubscribed 93.69 times, showcasing strong investor interest.
🔮 GMP expectations aligned with the positive listing, with an expected price of ₹676.
💊 Senores is a research-driven pharma company focusing on products for regulated markets.
Senores Pharmaceuticals made an impressive debut today, December 30, 2024!
📈 Shares listed at ₹593.70 on the BSE, a 51.84% premium over the IPO price of ₹391.
📊 On the NSE, they opened at ₹600, reflecting a 53.45% premium.
💥 The IPO was oversubscribed 93.69 times, showcasing strong investor interest.
🔮 GMP expectations aligned with the positive listing, with an expected price of ₹676.
💊 Senores is a research-driven pharma company focusing on products for regulated markets.